Jonathan Yong
Stock Analyst at UBS
(3.16)
# 986
Out of 4,667 analysts
109
Total ratings
56.86%
Success rate
9.5%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLOV Clover Health Investments | Initiates: Neutral | $4 | $3.35 | +19.40% | 3 | Oct 7, 2024 | |
| OSCR Oscar Health | Initiates: Neutral | $23 | $17.00 | +35.29% | 7 | Oct 7, 2024 | |
| PINC Premier | Maintains: Neutral | $33 → $25 | $22.23 | +12.46% | 2 | Aug 24, 2023 | |
| WBA Walgreens Boots Alliance | Maintains: Neutral | $33 → $30 | $8.24 | +264.08% | 5 | Aug 24, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $7.46 | +60.86% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $4.31 | +85.61% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $10.21 | +154.65% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $21.79 | -35.75% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $73.73 | +30.20% | 3 | Aug 8, 2023 | |
| SEM Select Medical Holdings | Maintains: Neutral | $29 → $32 | $38.09 | -15.99% | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $105 | $24.80 | +323.39% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $98.93 | -19.13% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $237.85 | -2.88% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $101 | $90.00 | +12.22% | 5 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $9.00 | +200.00% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $3.56 | +321.35% | 5 | Jun 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $35 → $38 | $20.06 | +89.43% | 2 | Jun 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $120.34 | -16.90% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $621.14 | -27.55% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $10 | $5.13 | +94.93% | 3 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $4.10 | +192.68% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $7.84 | +792.86% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $11.39 | +49.25% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $294.64 | +18.79% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $39.10 | +142.97% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $11.30 | -24.78% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $20.79 | +97.21% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $11.89 | +42.98% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $3.83 | +121.93% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $85.42 | -0.49% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $161.32 | -9.50% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $59.10 | +79.36% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $197.52 | -20.51% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $323.39 | +13.79% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $293.97 | +116.01% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $56.83 | +105.88% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $14.49 | +107.04% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $333.00 | -10.51% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $151.84 | -37.43% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $600.50 | -17.57% | 1 | Oct 15, 2021 |
Clover Health Investments
Oct 7, 2024
Initiates: Neutral
Price Target: $4
Current: $3.35
Upside: +19.40%
Oscar Health
Oct 7, 2024
Initiates: Neutral
Price Target: $23
Current: $17.00
Upside: +35.29%
Premier
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $25
Current: $22.23
Upside: +12.46%
Walgreens Boots Alliance
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $30
Current: $8.24
Upside: +264.08%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $7.46
Upside: +60.86%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $4.31
Upside: +85.61%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $10.21
Upside: +154.65%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $21.79
Upside: -35.75%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $73.73
Upside: +30.20%
Select Medical Holdings
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $38.09
Upside: -15.99%
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $24.80
Upside: +323.39%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $98.93
Upside: -19.13%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $237.85
Upside: -2.88%
Jul 27, 2023
Reiterates: Neutral
Price Target: $101
Current: $90.00
Upside: +12.22%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $9.00
Upside: +200.00%
Jun 30, 2023
Maintains: Neutral
Price Target: $13 → $15
Current: $3.56
Upside: +321.35%
Jun 22, 2023
Maintains: Outperform
Price Target: $35 → $38
Current: $20.06
Upside: +89.43%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $120.34
Upside: -16.90%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $621.14
Upside: -27.55%
May 10, 2023
Reiterates: Neutral
Price Target: $10
Current: $5.13
Upside: +94.93%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $4.10
Upside: +192.68%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $7.84
Upside: +792.86%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $11.39
Upside: +49.25%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $294.64
Upside: +18.79%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $39.10
Upside: +142.97%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $11.30
Upside: -24.78%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $20.79
Upside: +97.21%
Mar 7, 2023
Maintains: Neutral
Price Target: $20 → $17
Current: $11.89
Upside: +42.98%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $3.83
Upside: +121.93%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $85.42
Upside: -0.49%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $161.32
Upside: -9.50%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $59.10
Upside: +79.36%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $197.52
Upside: -20.51%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $323.39
Upside: +13.79%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $293.97
Upside: +116.01%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $56.83
Upside: +105.88%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $14.49
Upside: +107.04%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $333.00
Upside: -10.51%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $151.84
Upside: -37.43%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $600.50
Upside: -17.57%